المساهمون: Sang Joon Shin, Joong Bae Ahn, Kyung Soo Park, Yoon Jung Lee, Yong Sang Hong, Tae Won Kim, Hye Ryun Kim, Sun Young Rha, Jae Kyung Roh, Dal-Hyun Kim, Chin Kim, Hyun Cheol Chung, Rha, Sun Young, Park, Kyung Soo, Shin, Sang Joon, Ahn, Joong Bae, Lee, Yoon Jung, Chung, Hyun Cheol, Kim, Hye Ryun, Roh, Jae Kyung

مصطلحات موضوعية: Adenocarcinoma/blood, Adenocarcinoma/drug therapy, Adenocarcinoma/mortality, Adenocarcinoma/secondary, Adult, Aged, Angiogenesis Inhibitors/pharmacokinetics, Antineoplastic Agents, Phytogenic/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/blood, Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics, Camptothecin/analogs & derivatives, Camptothecin/therapeutic use, Cinnamates/pharmacokinetics, Colorectal Neoplasms/blood, Colorectal Neoplasms/drug therapy, Colorectal Neoplasms/mortality, Colorectal Neoplasms/pathology, Cyclohexanes/pharmacokinetics, Deoxycytidine/administration & dosage, Deoxycytidine/adverse effects, Deoxycytidine/analogs & derivatives, Deoxycytidine/blood, Deoxycytidine/pharmacokinetics, Disease Progression, Disease-Free Survival, Dose-Response Relationship, Drug

Relation: INVESTIGATIONAL NEW DRUGS; J01184; OAK-2012-00281; https://ir.ymlib.yonsei.ac.kr/handle/22282913/90568; http://link.springer.com/article/10.1007%2Fs10637-010-9625-x; T201200494; INVESTIGATIONAL NEW DRUGS, Vol.30(2) : 672-680, 2012

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/90568
http://link.springer.com/article/10.1007%2Fs10637-010-9625-x

المؤلفون: Lagercrantz, S

المصدر: Läkemedelsvärlden. 111(5):16

المساهمون: Sang Joon Shin, Hei-Cheul Jeung, Joong Bae Ahn, Sun Young Rha, Jae Kyung Roh, Kyung Soo Park, Dal-Hyun Kim, Chin Kim, Hyun Cheol Chung, Roh, Jae Kyung, Rha, Sun Young, Park, Kyung Soo, Shin, Sang Joon, Ahn, Joong Bae, Chung, Hyun Cheol, Jeung, Hei Cheul

مصطلحات موضوعية: Adult, Aged, Angiogenesis Inhibitors/adverse effects, Angiogenesis Inhibitors/pharmacokinetics, Angiogenesis Inhibitors/pharmacology, Angiogenesis Inhibitors/therapeutic use, Area Under Curve, Cell Line, Cinnamates/adverse effects, Cinnamates/pharmacokinetics, Cinnamates/pharmacology, Cinnamates/therapeutic use, Cyclohexanes/adverse effects, Cyclohexanes/pharmacokinetics, Cyclohexanes/pharmacology, Cyclohexanes/therapeutic use, Dose-Response Relationship, Drug, Drug Resistance, Neoplasm/drug effects, Endostatins/blood, Epoxy Compounds/adverse effects, Epoxy Compounds/pharmacokinetics, Epoxy Compounds/pharmacology, Epoxy Compounds/therapeutic use, Female, Humans, Male, Maximum Tolerated Dose, Middle Aged

وصف الملف: 650~658

Relation: INVESTIGATIONAL NEW DRUGS; J01184; OAK-2010-01011; https://ir.ymlib.yonsei.ac.kr/handle/22282913/101411; http://link.springer.com/article/10.1007%2Fs10637-009-9287-8; T201002130; INVESTIGATIONAL NEW DRUGS, Vol.28(5) : 650-658, 2010

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/101411
https://doi.org/10.1007/s10637-009-9287-8
http://link.springer.com/article/10.1007%2Fs10637-009-9287-8

المساهمون: LOUIS TONG, TIEN Y. WONG, Byeon, Suk Ho

مصطلحات موضوعية: Angiogenesis Inhibitors/pharmacokinetics, Animals, Antibodies, Monoclonal/pharmacokinetics, Monoclonal, Humanized, Aqueous Humor/metabolism, Bevacizumab, Biological Availability, Half-Life, Models, Biological, Rabbits, Ranibizumab, Tissue Distribution, Vascular Endothelial Growth Factor A/antagonists & inhibitors, Vitreous Body/metabolism

وصف الملف: 168-9; author reply 169-70

Relation: OPHTHALMOLOGY; J02432; OAK-2009-01187; https://ir.ymlib.yonsei.ac.kr/handle/22282913/104527; http://www.sciencedirect.com/science/article/pii/S0161642008009044; T200902970; OPHTHALMOLOGY, Vol.116(1) : 168-70, 2009

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/104527
https://doi.org/10.1016/j.ophtha.2008.09.016
http://www.sciencedirect.com/science/article/pii/S0161642008009044

المؤلفون: Fuchs, K., Kiss, A., Bize, P.E., Duran, R., Denys, A., Hopfgartner, G., Borchard, G., Jordan, O.

المصدر: Journal of controlled release, vol. 269, pp. 128-135

مصطلحات موضوعية: Angiogenesis Inhibitors/administration & dosage, Angiogenesis Inhibitors/pharmacokinetics, Animals, Cell Line, Tumor, Disease Models, Animal, Drug Delivery Systems, Liver/metabolism, Liver Neoplasms/metabolism, Mass Spectrometry, Microspheres, Optical Imaging, Rabbits, Sunitinib/administration & dosage, Sunitinib/pharmacokinetics, Biodistribution, Drug-eluting beads, Fluorescence imaging, MALDI-SRM mass spectrometry imaging, Sunitinib, Transarterial chemoembolization

Relation: info:eu-repo/semantics/altIdentifier/pmid/29101054; info:eu-repo/semantics/altIdentifier/eissn/1873-4995; https://serval.unil.ch/notice/serval:BIB_87D2648EE778

الاتاحة: https://serval.unil.ch/notice/serval:BIB_87D2648EE778
https://doi.org/10.1016/j.jconrel.2017.10.042